"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...

As Novo Nordisk races to get an oral successor to the weight loss sensation Wegovy through clinical trials, Viking Therapeutics is raising its sails for an attack. The biotech unveiled data from a ...

Wegovy pill, the first oral GLP-1 for weight loss, is FDA-approved for reducing cardiovascular risks in adults. Phase III OASIS 4 trial showed 16.6% mean weight loss with oral semaglutide, ...

WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused ...

Noticing thinning hair while taking Mounjaro? Learn why weight loss can cause hair loss, how to prevent shedding, and if your ...

Based on successful Phase 3 trial results, that approval is expected to come over the next few months. This new data, announced in a press release from pharma company Eli Lilly and yet to be ...

ZHENJIANG, China--(BUSINESS WIRE)--At 10:16 on January 17, State Grid Zhenjiang Power Supply Company successfully resolved a phase loss fault between Poles 17 and 18 on the 10 kV Antou 292 line of the ...

A new phase shifter does not need clean-room facilities for fabrication, so is inexpensive to manufacture. The liquid-metal enabled phase shifting elements have a 'passive' nature, unlike the 'active' ...

A new publication from Opto-Electronic Advances, 10.29026/oea.2023.220085 discuss broadband low-loss all-optical phase modulator using gas-filled hollow-core fiber. Optical phase modulators are key ...